NYSE:EVH
Evolent Health, Inc.
Evolent Health, Inc.'s revenue fell 26.6% in fiscal 2025 to $1.9B while operating margin fell to −21.9%.Summary generated from Evolent Health, Inc.'s SEC filings. Latest annual report filed Feb 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$1.9B
Revenue growth−26.6%
Revenue, 5-yr CAGR+15.2%
Gross margin21.3%
Operating margin−21.9%
Net margin−28.5%
ROIC−23.2%
Return on equity−75.5%
Debt / equity2.34
Free cash flown/a
FCF marginn/a
Share count change−0.4%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 908 | 1,352 | 1,964 | 2,555 | 1,876 |
| Operating income | −42 | 4 | −71 | −40 | −410 |
| Net income | −38 | −19 | −113 | −62 | −535 |
| Free cash flow | n/a | n/a | n/a | n/a | n/a |
Recent filings
- 4Insider transaction report
Aug 28, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 4Insider transaction report
Jul 6, 2026 - 8-KResults of a shareholder vote
Jun 4, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 7, 2026 - 8-KResults of operations and financial condition
May 7, 2026 - DEF 14AProxy statement
Apr 24, 2026